MCRB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Seres Therapeutics Inc (MCRB) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are neutral to bearish, options sentiment is weak, and financial performance shows no significant growth. Additionally, there are no recent positive catalysts or influential trading activities to support a buy decision.
The MACD is positive and expanding, indicating mild bullish momentum, but RSI is neutral at 54.252. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 8.788, with resistance at 9.194 and support at 8.381. Overall, the technical setup does not strongly favor a buy.
NULL. There is no recent news, congress trading data, or influential trading activity to act as a positive catalyst.
The company's financial performance is weak, with declining net income (-1.93% YoY) and EPS (-9.29% YoY). Additionally, there is no significant hedge fund or insider activity to support a bullish sentiment.
In Q4 2025, revenue remained flat at $438,000 (0.00% YoY), while net income dropped to -$15.34M (-1.93% YoY) and EPS declined to -1.66 (-9.29% YoY). Gross margin was stable at 100%. Overall, the financial performance shows no growth trends.
No recent analyst rating or price target changes are available.
